News Image

These stocks are gapping in today's session

By Mill Chart

Last update: Apr 17, 2024

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Today's gap up stocks

TickerChangeComment
SBFM5.0K%SUNSHINE BIOPHARMA INC's (NASDAQ:SBFM) shares rose 5.0K% to $3.69 with a gap of 4.0K%. Shareholders saw the stock price going 27.1% higher in the past month.
INVO228.0%INVO BIOSCIENCE INC's (NASDAQ:INVO) stock price increased by 228.0% to $2.49 with a gap of 132.0%. In the last month the share price dropped with 25.49%.
PLCE48.1%Exciting news for CHILDREN'S PLACE INC/THE's (NASDAQ:PLCE) stock! It advanced 48.1% to $10.53 in today's session, accompanied by a notable 20.16% gap. Shareholders saw the stock price going 45.93% lower in the past month.
CXAI28.9%In today's session, CXAPP INC's (NASDAQ:CXAI) stock experienced a notable rise of 28.9%, reaching $5.04 with a remarkable gap of 9.88%. In the last month the stock gained 38.16%.
VNDA28.52%VANDA PHARMACEUTICALS INC's (NASDAQ:VNDA) stock price is advancing with 28.52% to a price of $5.21 with a gap of 22.79%. The stock is trading 36.22% lower than a year ago.
AGFY21.8%AGRIFY CORP's (NASDAQ:AGFY) stock price increased by 21.8% to $0.37 with a gap of 12.0%. A press release (Agrify Corporation Reports Full-Year 2023 Earnings) was released two days ago.
RANI13.1%Exciting news for RANI THERAPEUTICS HOLDINGS-A's (NASDAQ:RANI) stock! It advanced 13.1% to $7.77 in today's session, accompanied by a notable 3.34% gap. In the last month the stock gained 106.0%.
UAL10.75%In today's session, UNITED AIRLINES HOLDINGS INC's (NASDAQ:UAL) stock experienced a notable rise of 10.75%, reaching $45.96 with a remarkable gap of 5.74%.
RMCO8.51%ROYALTY MANAGEMENT HOLDING C's (NASDAQ:RMCO) stock price increased by 8.51% to $1.02 with a gap of 3.03%. The stock is trading 24.19% lower than a month ago.
BEEM8.15%BEAM GLOBAL's (NASDAQ:BEEM) shares soared 8.15% to $5.97 in Wednesday's session, displaying an impressive 2.89% gap. Shareholders saw the stock price going 45.4% lower is the past year.

To see the full list of gap up stocks you can use our gap up stocks screener.

Top gap down stocks

TickerChangeComment
IZM-91.98%In today's session, ICZOOM GROUP INC -CLASS A's (NASDAQ:IZM) stock price decreased by 91.98% to $4.09, exhibiting a 92.99% gap. Shareholders saw the stock price going 461.0% higher in the past month.
TPET-30.99%TRIO PETROLEUM CORP's (NYSEARCA:TPET) shares recorded a 30.99% decline to $0.34, with a notable 46.25% gap during today's session. Shareholders saw the stock price going 344.0% higher in the past month.
TMQ-29.73%In today's session, TRILOGY METALS INC's (NYSEARCA:TMQ) stock price decreased by 29.73% to $0.35, exhibiting a 49.65% gap.
SXTC-25.93%CHINA SXT PHARMACEUTICALS IN's (NASDAQ:SXTC) shares fell 25.93% to $1.2 with a gap of 65.28%. In the last 6 months the stock lost 42.76%.
LGVN-24.96%LONGEVERON INC-A's (NASDAQ:LGVN) shares declined by 24.96% to $2.65, showing a 47.06% gap in today's session. The stock is trading 62.84% lower than 3 months ago.
SAGE-21.34%SAGE THERAPEUTICS INC's (NASDAQ:SAGE) shares suffered a 21.34% decline to $12.29 during Wednesday's session, accompanied by a 30.62% gap. A press release (Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease) was released earlier today.
OTRK-19.33%ONTRAK INC's (NASDAQ:OTRK) shares experienced a 19.33% decline to $0.37 during Wednesday's session, accompanied by a 27.85% gap. A press release (Ontrak Announces 2023 Fourth Quarter and Year End Financial Results) was released yesterday.
GPAK-18.9%Unfortunate news for GAMER PAKISTAN INC's (NASDAQ:GPAK) stock! It registered a 18.9% decline to $0.23 in today's session, accompanied by a 21.72% gap. In the last 6 months the stock lost 68.3%.
ISUN-18.52%Unfortunate news for ISUN INC's (NASDAQ:ISUN) stock! It registered a 18.52% decline to $0.17 in today's session, accompanied by a 25.61% gap. In the last year the stock lost 68.65%.
LIFWW-18.33%MSP RECOVERY INC -27's (NASDAQ:LIFWW) shares experienced a 18.33% decline to $0.0 during Wednesday's session, accompanied by a 19.67% gap. Shareholders saw the stock price going 87.5% higher in the past month.

Our gap down stocks screener will show you the full list.

Back

SAGE THERAPEUTICS INC

NASDAQ:SAGE (5/14/2024, 2:13:09 PM)

11.865

-0.3 (-2.51%)

SAGE News

News Image4 days ago - Market News VideoSage Therapeutics Ic Becomes Oversold (SAGE)
News Image7 days ago - Sage TherapeuticsSage Therapeutics to Participate in Upcoming May Investor Conferences
News Image8 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

News Image16 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

News Image19 days ago - InvestorPlaceSAGE Stock Earnings: Sage Therapeutics Misses EPS, Beats Revenue for Q1 2024

SAGE stock results show that Sage Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

News Image19 days ago - Sage Therapeutics, Inc.Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
News Imagea month ago - Yahoo FinanceNeurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data

Wednesday, Sage Therapeutics Inc (NASDAQ:SAGE) announced topline results from the PRECEDENT Phase 2 study of dalzanemdor (SAGE-718) in people with mild cognitive impairment in Parkinson’s Disease. The PRECEDENT Study did not meet its primary endpoint of demonstrating a statistically significant difference from baseline in participants treated with once-daily dalzanemdor versus placebo on the Wechsler Adult Intelligence Scale Fourth Edition-IV (WAIS-IV) Coding Test score at Day 42. WAIS-IV is the

News Imagea month ago - Investor's Business DailySage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark

Safe Therapeutics emphasized it's still testing the same drug in patients with Alzheimer's and Huntington's diseases.

SAGE Links
Follow us for more